secwatch / observer
8-K filed January 10, 2025, 6:59 PM ET ticker NXXT CIK 0001817004
regulatory confidence high sentiment negative materiality 0.80

NEXTNRG, INC. (NXXT): Nasdaq/NYSE listing notice — EzFill receives Nasdaq delisting notice for missing annual meeting deadline

NEXTNRG, INC.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

NEXTNRG, INC. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
shareholders
Rules
5620(a)
Exact text from the filing
January 10, 2025, EzFill Holdings, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company no longer complies with
View on SEC.gov
Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

NEXTNRG, INC. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

Exchange
nasdaq
Notice
deficiency notice
Rules
5620(a)
Exact text from the filing
January 10, 2025, EzFill Holdings, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company no longer complies with Nasdaq rules for continued listing (the “Rules”) because the Company has not yet held an annual meeting of stockholders within one year after the end of the Company’s fiscal year ended December 31, 2023, as required pursuant to Rule 5620(a) of the Rules (the “Annual Meeting Requirement”). Under the Rules, the Company has 45 calendar days to submit a plan to regain compliance an
View on SEC.gov

Browse all listing & compliance notices →

NEXTNRG, INC. filing history →

Source: SEC EDGAR
accession 0001493152-25-001804
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.